13F-HR filed by Frazier Life Sciences Management, L.P.
Frazier Life Sciences Management, L.P. filed this 13F-HR for the quarter ended 2024-06-30, filed 2024-08-15, with 49 holding rows worth $2,137,654,638.
- Accession
- 0001892134-24-000004
- Filer
- CIK 1892134
- Filed
- 2024-08-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2024
A holdings report, 49 entries on the cover page, a total value of $2,137,654,638 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,137,654,638 with VALUE read as dollars as filed, 13F file number 028-22504. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 12,226,943 | $234,879,575 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 6,495,392 | $222,077,452 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 988,460 | $181,520,794 | dollars as filed | |
| HILLEVAX INC | 43157M102 | COM | 10,617,062 | $153,522,717 | dollars as filed | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 10,109,279 | $104,125,574 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 2,371,304 | $97,365,742 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 3,632,604 | $92,013,859 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 8,785,284 | $81,703,141 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 1,754,834 | $79,090,368 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 1,039,405 | $78,485,472 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 3,731,067 | $67,196,517 | dollars as filed | |
| ANAPTYSBIO INC | 032724106 | COM | 2,165,591 | $54,269,710 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 3,314,349 | $47,925,487 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 3,687,867 | $43,443,073 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 1,587,527 | $43,148,984 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 997,455 | $38,711,229 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 16,216,216 | $38,270,270 | dollars as filed | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 871,974 | $37,599,519 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 875,667 | $35,727,214 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 1,561,230 | $33,613,282 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 8,157,385 | $32,874,262 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 4,142,855 | $29,289,985 | dollars as filed | |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 770,000 | $24,308,900 | dollars as filed | |
| PEPGEN INC COM | 713317105 | Stock | 1,502,788 | $23,984,496 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 373,100 | $22,076,327 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 7,381,090 | $21,995,648 | dollars as filed | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 1,148,591 | $21,823,229 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 425,000 | $17,467,500 | dollars as filed | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 4,623,324 | $16,089,168 | dollars as filed | |
| CEREVEL THERAPEUTICS HLDNG I | 15678U128 | COM | 393,000 | $16,069,770 | dollars as filed | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 4,401,371 | $15,844,936 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 1,152,456 | $13,391,539 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 832,220 | $13,307,198 | dollars as filed | |
| MACROGENICS INC | 556099109 | COM | 3,010,727 | $12,795,590 | dollars as filed | |
| Applied Therapeutics Inc | 03828A101 | Common Stock | 2,286,135 | $10,676,250 | dollars as filed | |
| PUMA BIOTECHNOLOGY INC | 74587V107 | COMMON STOCK | 3,062,558 | $9,983,939 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 1,000,000 | $8,010,000 | dollars as filed | |
| ELEVATION ONCOLOGY INC COM | 28623U101 | Stock | 2,958,579 | $7,988,163 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 936,576 | $7,895,336 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 470,338 | $7,642,993 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 285,331 | $7,595,511 | dollars as filed | |
| ADVERUM BIOTECHNOLOGIES INC | 00773U207 | COM NEW | 1,069,244 | $7,335,014 | dollars as filed | |
| ALLOGENE THERAPEUTICS INC | 019770106 | COM | 2,867,750 | $6,681,858 | dollars as filed | |
| AN2 THERAPEUTICS INC | 037326105 | COM | 2,088,889 | $4,491,111 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV-27 | N62509117 | WTS | 500,333 | $4,362,904 | dollars as filed | |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 1,195,179 | $4,003,850 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 108,762 | $3,685,944 | dollars as filed | |
| METAGENOMI THERAPEUTICS INC | 59102M104 | COM | 245,692 | $1,002,423 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 264,377 | $290,815 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001892134-24-000004 | this filing | 2024-08-15 | acceptance time not in the bulk data set |